Literature DB >> 25475071

Polycomb group proteins--epigenetic repressors with emerging roles in melanocytes and melanoma.

Jennifer M Huang1, Thomas J Hornyak.   

Abstract

Melanocytes undergo rapid and significant changes in their gene expression programs at regular intervals during development and the hair follicle cycle. In melanoma, the gene expression pattern found in normal melanocytes is disrupted. These gene expression patterns are regulated in part by post-translational histone modifications catalyzed by Polycomb group (PcG) proteins, which play a major role in many developmental processes and are often altered in cancer. In this review, we discuss the role of the PcG proteins in stem cell and cancer biology, in general, as well as in melanocyte development and melanomagenesis. Highlights include the discussion of newly identified treatments that target the activity of PcG proteins as well as new developments in the understanding of the role that these proteins play in melanocyte biology. Published 2014. This is a US Government work and is in the public domain in the USA.

Entities:  

Keywords:  Polycomb; epigenetic; melanocyte; melanoma; stem cell

Mesh:

Substances:

Year:  2015        PMID: 25475071      PMCID: PMC4780252          DOI: 10.1111/pcmr.12341

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  105 in total

1.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.

Authors:  Anna V Molofsky; Ricardo Pardal; Toshihide Iwashita; In-Kyung Park; Michael F Clarke; Sean J Morrison
Journal:  Nature       Date:  2003-10-22       Impact factor: 49.962

2.  EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.

Authors:  Chunxi Wang; Zhihui Liu; Chan-Wook Woo; Zhijie Li; Lifeng Wang; Jun S Wei; Victor E Marquez; Susan E Bates; Qihuang Jin; Javed Khan; Kai Ge; Carol J Thiele
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

Review 3.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

4.  Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.

Authors:  Isabel Hidalgo; Antonio Herrera-Merchan; Jose Manuel Ligos; Laura Carramolino; Javier Nuñez; Fernando Martinez; Orlando Dominguez; Miguel Torres; Susana Gonzalez
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

5.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.

Authors:  Syuzo Kaneko; Gang Li; Jinsook Son; Chong-Feng Xu; Raphael Margueron; Thomas A Neubert; Danny Reinberg
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

6.  Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).

Authors:  Michael T McCabe; Alan P Graves; Gopinath Ganji; Elsie Diaz; Wendy S Halsey; Yong Jiang; Kimberly N Smitheman; Heidi M Ott; Melissa B Pappalardi; Kimberly E Allen; Stephanie B Chen; Anthony Della Pietra; Edward Dul; Ashley M Hughes; Seth A Gilbert; Sara H Thrall; Peter J Tummino; Ryan G Kruger; Martin Brandt; Benjamin Schwartz; Caretha L Creasy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-08       Impact factor: 11.205

7.  Polycomb complexes act redundantly to repress genomic repeats and genes.

Authors:  Martin Leeb; Diego Pasini; Maria Novatchkova; Markus Jaritz; Kristian Helin; Anton Wutz
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

8.  Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.

Authors:  Ingeborg M Bachmann; Hanne E Puntervoll; Arie P Otte; Lars A Akslen
Journal:  Mod Pathol       Date:  2008-02-08       Impact factor: 7.842

9.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Authors:  Wei Xu; Hui Yang; Ying Liu; Ying Yang; Ping Wang; Se-Hee Kim; Shinsuke Ito; Chen Yang; Pu Wang; Meng-Tao Xiao; Li-xia Liu; Wen-qing Jiang; Jing Liu; Jin-ye Zhang; Bin Wang; Stephen Frye; Yi Zhang; Yan-hui Xu; Qun-ying Lei; Kun-Liang Guan; Shi-min Zhao; Yue Xiong
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 38.585

10.  Aebp2 as an epigenetic regulator for neural crest cells.

Authors:  Hana Kim; Keunsoo Kang; Muhammad B Ekram; Tae-Young Roh; Joomyeong Kim
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

View more
  4 in total

1.  The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.

Authors:  Matthew L Fisher; Gautam Adhikary; Dan Grun; David M Kaetzel; Richard L Eckert
Journal:  Mol Carcinog       Date:  2015-12-23       Impact factor: 4.784

Review 2.  Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.

Authors:  Jennifer M Huang; Ijeuru Chikeka; Thomas J Hornyak
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

3.  Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids.

Authors:  Viktoria Koroknai; Vikas Patel; István Szász; Róza Ádány; Margit Balazs
Journal:  Pathol Oncol Res       Date:  2020-07-01       Impact factor: 3.201

Review 4.  Current understanding of epigenetics role in melanoma treatment and resistance.

Authors:  Mohsen Karami Fath; Ali Azargoonjahromi; Asma Soofi; Faezeh Almasi; Shahnaz Hosseinzadeh; Saeed Khalili; Kamran Sheikhi; Saeid Ferdousmakan; Soroor Owrangi; Minoovash Fahimi; Hamidreza Zalpoor; Mohsen Nabi Afjadi; Zahra Payandeh; Navid Pourzardosht
Journal:  Cancer Cell Int       Date:  2022-10-12       Impact factor: 6.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.